The amnion patch market size has grown strongly in recent years. It will grow from $1.91 billion in 2025 to $2.07 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to limited availability of amniotic membrane products, reliance on fresh tissue grafts, growing demand for ocular surface reconstruction, increasing hospital and clinic procedures, lack of standardized preservation techniques.
The amnion patch market size is expected to see strong growth in the next few years. It will grow to $2.81 billion in 2030 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to development of cryopreserved and lyophilized amnion patches, rising adoption in corneal repair and ocular surgeries, growth in dental and orthopedic applications, increasing research and development initiatives, expansion of eye banks and tissue banks. Major trends in the forecast period include rising use of amnion patches in wound healing and tissue regeneration, increased adoption of cryopreserved and lyophilized products, expansion of ophthalmic and dental applications, growing focus on minimally invasive surgical procedures, enhanced regulatory compliance and quality standards for amniotic products.
The increasing prevalence of diabetes is expected to drive the growth of the amnion patch market going forward. The rise in diabetes prevalence is attributed to factors such as sedentary lifestyles, unhealthy dietary patterns, increasing obesity levels, aging populations, and genetic susceptibility. Amnion patches are used to treat diabetic foot ulcers caused by severe diabetes by promoting faster wound healing through the provision of bioactive tissue that supports cell regeneration and reduces inflammation. For instance, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that more than half a billion people worldwide were living with diabetes. This figure is projected to more than double, reaching 1.3 billion individuals by 2050. Therefore, the increasing prevalence of diabetes is driving the growth of the amnion patch market.
Companies operating in the amnion patch market are concentrating on developing innovative products, such as dehydrated dual-layer amniotic membrane patches, to deliver shelf-stable, biologically active scaffolds that support wound healing and protect tissue. A dehydrated dual-layer amniotic membrane patch is a two-layer allograft derived from placental tissue, processed to preserve extracellular matrix components while functioning as both a barrier and scaffold and remaining stable at room temperature. For example, in 2025, Mindsight Medical / Total Ancillary, a US-based provider of biologic wound care grafts, launched the RevoShield+ Dual Layer Amnio Patch. The patch is manufactured from dehydrated human amniotic membrane, offers a five-year shelf life at room temperature, and can be applied with or without glue or sutures. It reduces moisture loss, acts as a protective barrier, and supports tissue reconstruction in acute and chronic wounds, podiatry, Mohs surgery, and related applications.
In September 2023, Globus Medical, Inc., a US-based medical device company, merged with NuVasive to create a leading global organization advancing spine and orthopedic care through comprehensive procedural solutions and technologies. This merger brings together their complementary global scale, expanded commercial reach, extensive product portfolios, and shared commitment to product innovation, surgeon education, and improved operational capabilities. NuVasive Inc. is a US-based medical device company.
Major companies operating in the amnion patch market are Integra LifeSciences Corporation, AlloSource, Bio‑Tissue Inc., Infinity Biologics Inc., VIVEX Biologics Inc., Tissue Regenix Ltd, Celularity, Royal Biologics, NuVision Biotherapies Ltd, Olifant Biologics, MTF Biologics, BioHealing, MiMedx Group Inc, Amnio Technology LLC, Amniox Medical Inc, Regenative Labs LLC, Organogenesis Inc, Skye Biologics Holdings LLC, Human Regenerative Technologies LLC, Genesis Biologics, Ventris Medical LLC.
North America was the largest region in the amnion patch market in 2025. The regions covered in the amnion patch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the amnion patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the amnion patch market by increasing the cost of imported amniotic membrane products and preservation equipment. Segments such as cryopreserved and lyophilized transplantation-grade patches are particularly impacted, with regions like Asia-Pacific and North America facing higher import duties. This has led to increased product costs and supply chain adjustments. On the positive side, tariffs have encouraged local production, investment in domestic tissue banks, and innovation in preservation and packaging technologies.
The amnion patch market research report is one of a series of new reports that provides amnion patch market statistics, including amnion patch industry global market size, regional shares, competitors with a amnion patch market share, detailed amnion patch market segments, market trends and opportunities, and any further data you may need to thrive in the amnion patch industry. This amnion patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An amnion patch is a medical product made from the amniotic membrane and is commonly used in surgery and wound care. It utilizes the membrane’s natural anti-inflammatory and regenerative properties to support healing and tissue repair. The patch is placed over wounds or surgical areas to aid recovery, minimize scarring, and encourage tissue regeneration.
The major product types of amnion patches are transplantation-grade amnion patches, transplantation-grade amnion or chorion patches, and suspension liquid amnio patches. Transplantation-grade amnion patches are high-quality amniotic membrane products specially prepared for use in transplant-related medical procedures. Their applications include corneal repair, ocular surface reconstruction, amniotic membrane transplantation, dental procedures, wound healing, and orthopedic uses, and they are utilized by end-users such as hospitals, eye banks, clinics, and research institutions.
The amnion patch market consists of sales of amniotic fluid injections, amnion patch dressings, and amniotic membrane grafts. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The amnion patch market size is expected to see strong growth in the next few years. It will grow to $2.81 billion in 2030 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to development of cryopreserved and lyophilized amnion patches, rising adoption in corneal repair and ocular surgeries, growth in dental and orthopedic applications, increasing research and development initiatives, expansion of eye banks and tissue banks. Major trends in the forecast period include rising use of amnion patches in wound healing and tissue regeneration, increased adoption of cryopreserved and lyophilized products, expansion of ophthalmic and dental applications, growing focus on minimally invasive surgical procedures, enhanced regulatory compliance and quality standards for amniotic products.
The increasing prevalence of diabetes is expected to drive the growth of the amnion patch market going forward. The rise in diabetes prevalence is attributed to factors such as sedentary lifestyles, unhealthy dietary patterns, increasing obesity levels, aging populations, and genetic susceptibility. Amnion patches are used to treat diabetic foot ulcers caused by severe diabetes by promoting faster wound healing through the provision of bioactive tissue that supports cell regeneration and reduces inflammation. For instance, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that more than half a billion people worldwide were living with diabetes. This figure is projected to more than double, reaching 1.3 billion individuals by 2050. Therefore, the increasing prevalence of diabetes is driving the growth of the amnion patch market.
Companies operating in the amnion patch market are concentrating on developing innovative products, such as dehydrated dual-layer amniotic membrane patches, to deliver shelf-stable, biologically active scaffolds that support wound healing and protect tissue. A dehydrated dual-layer amniotic membrane patch is a two-layer allograft derived from placental tissue, processed to preserve extracellular matrix components while functioning as both a barrier and scaffold and remaining stable at room temperature. For example, in 2025, Mindsight Medical / Total Ancillary, a US-based provider of biologic wound care grafts, launched the RevoShield+ Dual Layer Amnio Patch. The patch is manufactured from dehydrated human amniotic membrane, offers a five-year shelf life at room temperature, and can be applied with or without glue or sutures. It reduces moisture loss, acts as a protective barrier, and supports tissue reconstruction in acute and chronic wounds, podiatry, Mohs surgery, and related applications.
In September 2023, Globus Medical, Inc., a US-based medical device company, merged with NuVasive to create a leading global organization advancing spine and orthopedic care through comprehensive procedural solutions and technologies. This merger brings together their complementary global scale, expanded commercial reach, extensive product portfolios, and shared commitment to product innovation, surgeon education, and improved operational capabilities. NuVasive Inc. is a US-based medical device company.
Major companies operating in the amnion patch market are Integra LifeSciences Corporation, AlloSource, Bio‑Tissue Inc., Infinity Biologics Inc., VIVEX Biologics Inc., Tissue Regenix Ltd, Celularity, Royal Biologics, NuVision Biotherapies Ltd, Olifant Biologics, MTF Biologics, BioHealing, MiMedx Group Inc, Amnio Technology LLC, Amniox Medical Inc, Regenative Labs LLC, Organogenesis Inc, Skye Biologics Holdings LLC, Human Regenerative Technologies LLC, Genesis Biologics, Ventris Medical LLC.
North America was the largest region in the amnion patch market in 2025. The regions covered in the amnion patch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the amnion patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the amnion patch market by increasing the cost of imported amniotic membrane products and preservation equipment. Segments such as cryopreserved and lyophilized transplantation-grade patches are particularly impacted, with regions like Asia-Pacific and North America facing higher import duties. This has led to increased product costs and supply chain adjustments. On the positive side, tariffs have encouraged local production, investment in domestic tissue banks, and innovation in preservation and packaging technologies.
The amnion patch market research report is one of a series of new reports that provides amnion patch market statistics, including amnion patch industry global market size, regional shares, competitors with a amnion patch market share, detailed amnion patch market segments, market trends and opportunities, and any further data you may need to thrive in the amnion patch industry. This amnion patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An amnion patch is a medical product made from the amniotic membrane and is commonly used in surgery and wound care. It utilizes the membrane’s natural anti-inflammatory and regenerative properties to support healing and tissue repair. The patch is placed over wounds or surgical areas to aid recovery, minimize scarring, and encourage tissue regeneration.
The major product types of amnion patches are transplantation-grade amnion patches, transplantation-grade amnion or chorion patches, and suspension liquid amnio patches. Transplantation-grade amnion patches are high-quality amniotic membrane products specially prepared for use in transplant-related medical procedures. Their applications include corneal repair, ocular surface reconstruction, amniotic membrane transplantation, dental procedures, wound healing, and orthopedic uses, and they are utilized by end-users such as hospitals, eye banks, clinics, and research institutions.
The amnion patch market consists of sales of amniotic fluid injections, amnion patch dressings, and amniotic membrane grafts. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Amnion Patch Market Characteristics
3. Amnion Patch Market Supply Chain Analysis
4. Global Amnion Patch Market Trends and Strategies
5. Amnion Patch Market Analysis of End Use Industries
7. Global Amnion Patch Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Amnion Patch Total Addressable Market (TAM) Analysis for the Market
9. Amnion Patch Market Segmentation
10. Amnion Patch Market Regional and Country Analysis
11. Asia-Pacific Amnion Patch Market
12. China Amnion Patch Market
13. India Amnion Patch Market
14. Japan Amnion Patch Market
15. Australia Amnion Patch Market
16. Indonesia Amnion Patch Market
17. South Korea Amnion Patch Market
18. Taiwan Amnion Patch Market
19. South East Asia Amnion Patch Market
20. Western Europe Amnion Patch Market
21. UK Amnion Patch Market
22. Germany Amnion Patch Market
23. France Amnion Patch Market
24. Italy Amnion Patch Market
25. Spain Amnion Patch Market
26. Eastern Europe Amnion Patch Market
27. Russia Amnion Patch Market
28. North America Amnion Patch Market
29. USA Amnion Patch Market
30. Canada Amnion Patch Market
31. South America Amnion Patch Market
32. Brazil Amnion Patch Market
33. Middle East Amnion Patch Market
34. Africa Amnion Patch Market
36. Amnion Patch Market Competitive Landscape and Company Profiles
37. Amnion Patch Market Other Major and Innovative Companies
40. Amnion Patch Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Amnion Patch Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses amnion patch market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for amnion patch? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The amnion patch market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Transplantation Grade Amnion Patches; Transplantation Grade Amnion Or Chorion Patches; Suspension Liquid Amnio Patch2) By Application: Corneal Repair; Ocular Surface Reconstruction; Amniotic Membrane Transplantation; Dental Applications; Wound Healing; Orthopedic Applications
3) By End User: Hospitals; Eye Banks; Clinics; Research Institutes
Subsegments:
1) By Transplantation Grade Amnion Patches: Cryopreserved Transplantation Grade Amnion Patches; Lyophilized Transplantation Grade Amnion Patches; Fresh Transplantation Grade Amnion Patches2) By Transplantation Grade Amnion or Chorion Patches: Cryopreserved Amnion or Chorion Patches; Lyophilized Amnion or Chorion Patches; Fresh Amnion Or Chorion Patches
3) By Suspension Liquid Amnio Patch: Cryopreserved Suspension Liquid Amnio Patch; Lyophilized Suspension Liquid Amnio Patch; Fresh Suspension Liquid Amnio Patch
Companies Mentioned: Integra LifeSciences Corporation; AlloSource; Bio‑Tissue Inc.; Infinity Biologics Inc.; VIVEX Biologics Inc.; Tissue Regenix Ltd; Celularity; Royal Biologics; NuVision Biotherapies Ltd; Olifant Biologics; MTF Biologics; BioHealing; MiMedx Group Inc; Amnio Technology LLC; Amniox Medical Inc; Regenative Labs LLC; Organogenesis Inc; Skye Biologics Holdings LLC; Human Regenerative Technologies LLC; Genesis Biologics; Ventris Medical LLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Amnion Patch market report include:- Integra LifeSciences Corporation
- AlloSource
- Bio‑Tissue Inc.
- Infinity Biologics Inc.
- VIVEX Biologics Inc.
- Tissue Regenix Ltd
- Celularity
- Royal Biologics
- NuVision Biotherapies Ltd
- Olifant Biologics
- MTF Biologics
- BioHealing
- MiMedx Group Inc
- Amnio Technology LLC
- Amniox Medical Inc
- Regenative Labs LLC
- Organogenesis Inc
- Skye Biologics Holdings LLC
- Human Regenerative Technologies LLC
- Genesis Biologics
- Ventris Medical LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.07 Billion |
| Forecasted Market Value ( USD | $ 2.81 Billion |
| Compound Annual Growth Rate | 8.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
